全文获取类型
收费全文 | 412369篇 |
免费 | 27558篇 |
国内免费 | 3221篇 |
专业分类
耳鼻咽喉 | 5525篇 |
儿科学 | 9188篇 |
妇产科学 | 10720篇 |
基础医学 | 57944篇 |
口腔科学 | 12291篇 |
临床医学 | 33266篇 |
内科学 | 85496篇 |
皮肤病学 | 9274篇 |
神经病学 | 29880篇 |
特种医学 | 15193篇 |
外国民族医学 | 95篇 |
外科学 | 64892篇 |
综合类 | 11226篇 |
现状与发展 | 2篇 |
一般理论 | 67篇 |
预防医学 | 19983篇 |
眼科学 | 10076篇 |
药学 | 33636篇 |
7篇 | |
中国医学 | 2807篇 |
肿瘤学 | 31580篇 |
出版年
2021年 | 3687篇 |
2019年 | 3575篇 |
2018年 | 5557篇 |
2017年 | 4196篇 |
2016年 | 4262篇 |
2015年 | 4943篇 |
2014年 | 6896篇 |
2013年 | 8927篇 |
2012年 | 12256篇 |
2011年 | 12411篇 |
2010年 | 7570篇 |
2009年 | 6974篇 |
2008年 | 11093篇 |
2007年 | 11963篇 |
2006年 | 11829篇 |
2005年 | 10792篇 |
2004年 | 10139篇 |
2003年 | 9817篇 |
2002年 | 9393篇 |
2001年 | 29305篇 |
2000年 | 29828篇 |
1999年 | 24597篇 |
1998年 | 5512篇 |
1997年 | 4555篇 |
1996年 | 4098篇 |
1995年 | 3702篇 |
1994年 | 3319篇 |
1993年 | 3015篇 |
1992年 | 16530篇 |
1991年 | 15267篇 |
1990年 | 14593篇 |
1989年 | 14376篇 |
1988年 | 13014篇 |
1987年 | 12425篇 |
1986年 | 11457篇 |
1985年 | 10648篇 |
1984年 | 7148篇 |
1983年 | 5784篇 |
1982年 | 2838篇 |
1979年 | 5667篇 |
1978年 | 3449篇 |
1977年 | 3091篇 |
1976年 | 2354篇 |
1975年 | 2741篇 |
1974年 | 3192篇 |
1973年 | 2971篇 |
1972年 | 2958篇 |
1971年 | 2866篇 |
1970年 | 2609篇 |
1969年 | 2646篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Y. Ermias I.A. Morgan K.M. Curtis M.K. Whiteman L.G. Horton L.B. Zapata 《Contraception》2019,99(5):300-305
ObjectiveIdentify factors associated with healthcare providers' frequency of depot medroxyprogesterone acetate (DMPA) provision to adolescents.Study designWe analyzed data from surveys mailed to a nationally representative sample of public-sector providers and office-based physicians (n=1984). We estimated adjusted odds ratios (aORs) and 95% confidence intervals (CIs) of factors associated with frequent DMPA provision to adolescents in the past year.ResultsAlthough most providers (>95%) considered DMPA safe for adolescents, fewer reported frequent provision (89% of public-sector providers; 64% of office-based physicians). Among public-sector providers, factors associated with lower odds of frequent provision included working in settings without Title X funding (aOR 0.44, 95% CI 0.30–0.64), reporting primary care as their primary clinical focus versus reproductive or adolescent health (aOR 0.42, 95% CI 0.28–0.61), and providing fewer patients with family planning services. Among office-based physicians, factors associated with lower odds of frequent provision included specializing in obstetrics/gynecology (aOR 0.50, 95% CI 0.27–0.91) and family medicine (aOR 0.21, 95% CI 0.09–0.47) versus adolescent medicine, completing training ≥15 versus <5 years ago (aOR 0.27, 95% CI 0.09–0.83), and reporting that 0–24% of patients pay with Medicaid or other government healthcare assistance versus ≥50% (aOR 0.23, 95% CI 0.09–0.61). The reason most commonly reported by providers for infrequent DMPA provision was patient preference for another method.ConclusionsWhile most providers reported frequently providing DMPA to adolescents, training on evidence-based recommendations for contraception, focused on subgroups of providers with lower odds of frequent DMPA provision, may increase adolescents' access to contraception.ImplicationsAlthough >95% of providers considered depot medroxyprogesterone (DMPA) a safe contraceptive for adolescents, only 89% of public-sector providers and 64% of office-based physicians reported frequently providing DMPA to adolescents. Provider training on evidence-based recommendations for contraception counseling and provision may increase adolescents' access to DMPA and all methods of contraception. 相似文献
42.
Prevention Science - This study aimed to evaluate the effectiveness of the drug and violence resistance educational program (PROERD) on short-term secondary outcomes, such as intentions to use... 相似文献
43.
44.
45.
46.
It is hypothesized that persons who use drugs (PWUD) in Vietnam who are also HIV-positive may face additional challenges in psychosocial outcomes, and these challenges may extend to their family members. In this study, we examined depressive symptoms, stigma, social support, and caregiver burden of HIV-positive PWUD and their family members, compared to the outcomes of HIV-negative PWUD and their family members. Baseline, 3-month, and 6-month assessment data were gathered from 83 PWUD and 83 family members recruited from four communes in Phú Th? Province, Vietnam. For PWUD, although we observed a general decline in overall stigma over time for both groups, HIV-positive PWUD consistently reported significantly higher overall stigma for all three periods. Depressive symptoms among family members in both groups declined over time; however, family members of HIV-positive PWUD reported higher depressive symptoms across all three periods. In addition, family members of HIV-positive PWUD reported lower levels of tangible support across all three periods. Caregiver burden among family members of HIV-positive PWUD increased significantly over time, whereas the reported burden among family members of HIV-negative PWUD remained relatively unchanged. The findings highlight the need for future interventions for PWUD and family members, with targeted and culturally specific strategies to focus on the importance of addressing additional stigma experienced by PWUD who are HIV-positive. Such challenges may have direct negative impact on their family members' depressive symptoms, tangible support, and caregiver burden. 相似文献
47.
48.
Parallel enzyme‐linked immunosorbent assay screening for human immunodeficiency virus among blood donors in five Chinese blood centres: a retrospective analysis
下载免费PDF全文
![点击此处可从《Transfusion medicine (Oxford, England)》网站下载免费的PDF全文](/ch/ext_images/free.gif)
49.
50.
Ana M. Gómez Angelica Imitola Diana Henao Maira García-Jaramillo Marga Giménez Clara Viñals Bruno Grassi Mariana Torres Isabella Zuluaga Oscar Mauricio Muñoz Martin Rondón Fabián León-Vargas Ignacio Conget 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2021,15(1):267-272
Background and aimsDespite using sensor-augmented pump therapy (SAPT) with predictive low-glucose management (PLGM), hypoglycemia is still an issue in patients with type 1 Diabetes (T1D). Our aim was to determine factors associated with clinically significant hypoglycemia (<54 mg/dl) in persons with T1D treated with PLGM-SAPT.Methodology: This is a multicentric prospective real-life study performed in Colombia, Chile and Spain. Patients with T1D treated with PLGM-SAPT, using sensor ≥70% of time, were included. Data regarding pump and sensor use patterns and carbohydrate intake from 28 consecutive days were collected. A bivariate and multivariate Poisson regression analysis was carried out, to evaluate the association between the number of events of <54 mg/dl with the clinical variables and patterns of sensor and pump use.Results188 subjects were included (41 ± 13.8 years-old, 23 ± 12 years disease duration, A1c 7.2% ± 0.9). The median of events <54 mg/dl was four events/patient/month (IQR 1–10), 77% of these events occurred during day time. Multivariate analysis showed that the number of events of hypoglycemia were higher in patients with previous severe hypoglycemia (IRR1.38; 95% CI 1.19–1.61; p < 0.001), high glycemic variability defined as Coefficient of Variation (CV%) > 36% (IRR 2.09; 95%CI 1.79–2.45; p < 0.001) and hypoglycemia unawareness. A protector effect was identified for adequate sensor calibration (IRR 0.77; 95%CI 0.66–0.90; p:0.001), and the use of bolus wizard >60% (IRR 0.74; 95%CI 0.58–0.95; p:0.017).ConclusionIn spite of using advanced SAPT, clinically significant hypoglycemia is still a non-negligible risk. Only the identification and intervention of modifiable factors could help to prevent and reduce hypoglycemia in clinical practice. 相似文献